Last reviewed · How we verify
Hypotylin (metipamide)
Hypotylin (generic name: metipamide) is a metipamide drug. It is currently in unknown development for Hypertensive disorder.
Metipamide works by inhibiting gastric acid secretion, reducing the amount of acid produced in the stomach.
Hypotylin (metipamide) is a small molecule drug in the metipamide class, originally developed by an unknown entity and currently owned by an unknown entity. It is used to treat hypertensive disorders. The commercial status of Hypotylin is unknown, and it is not clear if it is patented or available as a generic medication. Key safety considerations for Hypotylin are not well-documented. Further research is needed to fully understand its pharmacology and clinical use.
At a glance
| Generic name | metipamide |
|---|---|
| Drug class | metipamide |
| Therapeutic area | Cardiovascular |
| Phase | unknown |
Mechanism of action
Think of it like a fire extinguisher for your stomach. Metipamide helps put out the flames of acid production, which can help reduce symptoms of conditions like heartburn and acid reflux. This can make it easier to digest food and reduce discomfort.
Approved indications
- Hypertensive disorder
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hypotylin CI brief — competitive landscape report
- Hypotylin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Hypotylin
What is Hypotylin?
How does Hypotylin work?
What is Hypotylin used for?
What is the generic name of Hypotylin?
What drug class is Hypotylin in?
What development phase is Hypotylin in?
Related
- Drug class: All metipamide drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Hypertensive disorder
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing